These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22934293)

  • 1. Comparison of thrombin generation for paired-platelet-rich plasma collected with and without corn trypsin inhibitor from hemophiliacs treated with factor-VIII inhibitor bypassing agents.
    Tripodi A; Chantarangkul V; Mancuso ME; Lemma L; Clerici M; Santagostino E
    J Thromb Haemost; 2012 Apr; 10(4):716-9. PubMed ID: 22934293
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe hemophiliacs.
    Mohammed BM; Martin EJ; Salinas V; Carmona R; Young G; Brophy DF
    J Thromb Haemost; 2014 Sep; 12(9):1558-61. PubMed ID: 25041427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay.
    Turecek PL; Váradi K; Keil B; Negrier C; Berntorp E; Astermark J; Bordet JC; Morfini M; Linari S; Schwarz HP
    Pathophysiol Haemost Thromb; 2003; 33(1):16-22. PubMed ID: 12853708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA.
    Parmar N; Berry LR; Paredes N; Chan AK
    Clin Lab; 2005; 51(3-4):157-66. PubMed ID: 15819171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
    Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoglu B; Kavakli K
    Clin Appl Thromb Hemost; 2013; 19(4):389-94. PubMed ID: 22395575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux.
    Szlam F; Sreeram G; Solomon C; Levy JH; Molinaro RJ; Tanaka KA
    Thromb Res; 2011 Feb; 127(2):135-40. PubMed ID: 21144556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII in the treatment of hemophilia A.
    Rea CJ; Foley JH; Sørensen B
    N Engl J Med; 2012 Jan; 366(3):281-3. PubMed ID: 22256823
    [No Abstract]   [Full Text] [Related]  

  • 8. Danazol-induced factor VIII and IX bypassing activity in hemophiliacs.
    Garewal HS; Corrigan JJ; Jeter MA; Damiano ML; Durie BG
    Thromb Res; 1985 Jul; 39(1):117-25. PubMed ID: 3929420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of the management of severe hemophilia A with inhibitors: two case reports emphasizing the potential interest of a high-purity human Factor VIII/von Willebrand factor concentrate and individually tailored prophylaxis guided by thrombin-generation test.
    Mathieu S; Crampe C; Dargaud Y; Lavigne-Lissalde G; Escuriola-Ettingshausen C; Tardy B; Meley R; Thouvenin S; Stephan JL; Berger C
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):940-5. PubMed ID: 26517064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostatic response to factor VIII administration in patients with haemophilia A measured by thrombin generation and correlation with factor concentrate use.
    Hugenholtz GC; Luddington R; Baglin T
    Haemophilia; 2016 Jan; 22(1):e42-5. PubMed ID: 26388112
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro evidence of a tissue factor-independent mode of action of recombinant factor VIIa in hemophilia.
    Augustsson C; Persson E
    Blood; 2014 Nov; 124(20):3172-4. PubMed ID: 25232061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some recent advances in the study of hemostasis.
    Ratnoff OD
    Circ Res; 1974 Jul; 35(1):1-14. PubMed ID: 4601719
    [No Abstract]   [Full Text] [Related]  

  • 13. Promising coagulation factor VIII bypassing strategies for patients with haemophilia A.
    Duan X; Tang M; Zhang J; Yu H; Xu R
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):539-52. PubMed ID: 24614429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN).
    van 't Veer C; Golden NJ; Kalafatis M; Simioni P; Bertina RM; Mann KG
    Blood; 1997 Oct; 90(8):3067-72. PubMed ID: 9376587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.
    Santagostino E; Mancuso ME; Tripodi A; Chantarangkul V; Clerici M; Garagiola I; Mannucci PM
    J Thromb Haemost; 2010 Apr; 8(4):737-43. PubMed ID: 20102490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with hemophilia A and B.
    Hansson KM; Gustafsson D; Skärby T; Frison L; Berntorp E
    J Thromb Haemost; 2015 Jul; 13(7):1293-300. PubMed ID: 25944555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors--a thrombin generation-guided pilot study.
    Livnat T; Martinowitz U; Azar-Avivi S; Zivelin A; Brutman-Barazani T; Lubetsky A; Kenet G
    Haemophilia; 2013 Sep; 19(5):782-9. PubMed ID: 23659442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients.
    Keularts IM; Hamulyak K; Hemker HC; Béguin S
    Thromb Haemost; 2000 Oct; 84(4):638-42. PubMed ID: 11057863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive.
    Waters EK; Hilden I; Sørensen BB; Ezban M; Holm PK
    J Thromb Haemost; 2015 Nov; 13(11):2041-52. PubMed ID: 26340413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIa-triggered thrombin generation in severe haemophilia A.
    Desborough MJR; Naeem H; Baker P; Curry N
    Br J Haematol; 2019 Feb; 184(4):637-640. PubMed ID: 29468639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.